Medical News

RSS

Actor Stephen McGann explains how issues of medical accuracy were addressed in Call the Midwife drama

Actor Stephen McGann, who plays GP Dr Patrick Turner in the hit BBC period drama Call the Midwife, has described the steps taken by the writers, production team and actors to ensure the series has sufficient medical accuracy and authenticity. In an essay published today by the Journal of the Royal Society of Medicine, McGann writes of the unique insight that the role of Dr Turner has given him into questions regarding the way popular culture portrays medics and medicine.

24 Apr 2015

ELC Group signs landmark deal with Chinese pharmaceutical giant

ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it has been awarded a 1.5 million Euro contract by one of China’s biggest pharmaceutical companies.

24 Apr 2015

Copley Scientific to showcase new accessories at RDD Europe 2015

Cascade impaction is used for all inhaled product testing but is a manually intensive process. Copley Scientific’s sample preparation tools help to alleviate bottlenecks, ensure that testing is consistent, reproducible and controlled, and also reduce the risk of repetitive strain injury (RSI)...

24 Apr 2015

WHO: Progress towards global vaccination targets 'far off track'

Progress towards global vaccination targets for 2015 is far off track with 1 in 5 children still missing out on routine life-saving immunizations that could avert 1.5 million deaths each year from preventable diseases. In the lead-up to World Immunization Week 2015 (24 -30 April), the World Health Organization is calling for renewed efforts to get progress back on course.

24 Apr 2015

First CE marked FGF23 ELISA assay launched at Biomedica Immunoassays

The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically detects both intact and C-terminal fragments of FGF23 in human serum and plasma. The FGF23 ELISA assay complements the existing Biomedica assays directed against chronic kidney disease - mineral and bone disorder (CKD-MBD) in a growing collection.

24 Apr 2015

Lucideon Receives ISO 17025 Accreditation for Wear Testing

Lucideon, the international materials technology company, has been awarded ISO/IEC 17025:2005 accreditation for the total wear testing of hip joints...

From Lucideon 24 Apr 2015

Mobidiag to present two new diagnostic platforms for infectious diseases at ECCMID 2015

Mobidiag Ltd, a Finnish molecular diagnostics company specializing in the development of innovative diagnostics solutions for infectious diseases, today announced the first public presentation of two new diagnostic platforms – Novodiag and Amplidiag Easy – at ECCMID 2015 in Copenhagen on April 25-28.

24 Apr 2015

New study finds high mortality risks from alcohol and drug abuse among ex-prisoners

Alcohol and drug misuse are responsible for around a third of all deaths in former male prisoners and half in female ex-prisoners, a new study of almost 48000 ex-prisoners published in The Lancet Psychiatry journal has found. Moreover, the research shows that a substantial proportion of these deaths are from preventable causes, including accidents and suicide (42% in men and 70% in women).

24 Apr 2015

Findings suggest development of 'post-infection' vaccine to reduce TB rates in China

A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented today at the Fourth Global Forum on TB Vaccines in Shanghai.

24 Apr 2015

NUH develops new treatment guidelines to support women suffering from Hyperemesis

Nottingham’s hospitals (NUH) is the first Trust in the country to develop a new treatment plan to support women suffering from severe sickness during pregnancy.

24 Apr 2015

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).

24 Apr 2015

Getinge secures EUR 160 million loan from EIB for development of new medical devices

The European Investment Bank has provided a EUR 160 million loan to Getinge AB, a global medical technology company, for its research and development in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge’s research addresses unmet medical needs and targets the development of new devices with higher efficiency and safety for increased positive outcomes for both caregivers and patients.

24 Apr 2015

New method offers quick spectral analysis of blood and melanin contents in skin sites

Many factors can change skin pigmentation, including aging, exposure to UV light, certain drugs, as well as certain diseases. A simple technique for measuring skin pigmentation could be a helpful tool for research and diagnostics. The same goes for measuring the skin blood content.

24 Apr 2015

Recommended alcoholic hepatitis treatments fail to increase patients' survival

The main drugs used to treat alcoholic hepatitis are not effective at increasing patients' survival, a major study has found. In a trial of over 1,000 patients, prednisolone and pentoxifylline, treatments recommended in international guidelines, did not achieve a statistically significant reduction in mortality after 28 days, 90 days or a year.

24 Apr 2015

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today announced that its novel solid dose formulation of teriparatide (parathyroid hormone) achieved successful results in a pre-clinical proof-of-concept study comparing it with the currently marketed liquid product (Forteo/Forsteo).

24 Apr 2015

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

24 Apr 2015

Mitotech reports positive results from SkQ1 Phase II trial in patients with moderate to severe dry eye syndrome

Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company developing novel antioxidant molecules targeting mitochondria, today announced that it has achieved significant positive results in its U.S. Phase II clinical trial of SkQ1 compound in patients with moderate to severe dry eye syndrome.

24 Apr 2015

Mitotech reports positive results from SkQ1 Phase II trial in patients with moderate to severe dry eye syndrome

24 Apr 2015

Cardiff scientists make breakthrough asthma discovery

Cardiff University scientists have for the first time identified the potential root cause of asthma and an existing drug that offers a new treatment.

24 Apr 2015

Twins pilot study shows genes may make some people more attractive to mosquitoes

The likelihood of being bitten by mosquitoes could be down to our genes, according to a study carried out on twins. Research from the London School of Hygiene & Tropical Medicine found, for the first time, an underlying genetic component to how attractive we are to mosquitoes and this is likely to be caused by genetic control of our body odour.

24 Apr 2015

Medical News

Actor Stephen McGann explains how issues of medical accuracy were addressed in Call the Midwife drama

ELC Group signs landmark deal with Chinese pharmaceutical giant

Copley Scientific to showcase new accessories at RDD Europe 2015

WHO: Progress towards global vaccination targets 'far off track'

First CE marked FGF23 ELISA assay launched at Biomedica Immunoassays

Lucideon Receives ISO 17025 Accreditation for Wear Testing

Mobidiag to present two new diagnostic platforms for infectious diseases at ECCMID 2015

New study finds high mortality risks from alcohol and drug abuse among ex-prisoners

Findings suggest development of 'post-infection' vaccine to reduce TB rates in China

NUH develops new treatment guidelines to support women suffering from Hyperemesis

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Getinge secures EUR 160 million loan from EIB for development of new medical devices

New method offers quick spectral analysis of blood and melanin contents in skin sites

Recommended alcoholic hepatitis treatments fail to increase patients' survival

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Mitotech reports positive results from SkQ1 Phase II trial in patients with moderate to severe dry eye syndrome

Mitotech reports positive results from SkQ1 Phase II trial in patients with moderate to severe dry eye syndrome

Cardiff scientists make breakthrough asthma discovery

Twins pilot study shows genes may make some people more attractive to mosquitoes

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News